Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500, Dow futures muted after big bank earnings, chip slide weighs
- Oil eases as traders monitor Russian diesel deal, Saudi attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.40 | 52 Week High | $37.39 | |||
| Open | $28.40 | 52 Week Low | $28.25 | |||
| Day High | $28.40 | P/E | 17.21 | |||
| Day Low | $28.40 | EPS | $1.65 | |||
| Volume | 144,353 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.40 | 52 Week High | $37.39 | |||
| Open | $28.40 | 52 Week Low | $28.25 | |||
| Day High | $28.40 | P/E | 17.21 | |||
| Day Low | $28.40 | EPS | $1.65 | |||
| Volume | 144,353 | |||||
